Ann Clin Microbiol.  2024 Dec;27(4):217-219. 10.5145/ACM.2024.27.4.1.

Fungal infections: rising threats, diagnostic challenges, and the path forward for clinical microbiology laboratories

• Kim J

• KMID: 2566087
• DOI: http://doi.org/10.5145/ACM.2024.27.4.1

Reference

1. Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis 2024;24:e428-38.

2. World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action 2022. https://www.who.int/publications/i/ item/9789240060241 [Online] (last visited on 17 December 2024).

3. Silva LN, de Mello TP, de Souza Ramos L, Branquinha MH, Roudbary M, dos Santos ALS. Fungal infections in COVID-19-positive patients: a lack of optimal treatment options. Curr Top Med Chem 2020;20:1951-7.

4. Kim J. Fungal identification based on the polyphasic approach: a clinical practice guideline. Ann Clin Microbiol 2024;27:221-30.

5. Kwon YJ and Shin JH. Candida and candidemia in Korea. Ann Clin Microbiol 2024;27: 23144.

6. Won EJ. Current nonculture-based diagnosis of candidemia. Ann Clin Microbiol 2024;27:24555.

7. Kim MH. Current epidemiology and implication for microbiological diagnosis of cryptococcal infections in Korea. Ann Clin Microbiol 2024;27:257-65.